Literature DB >> 8891282

Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm.

H Ino1, T Chiba.   

Abstract

Cyclin-dependent kinase 5 (CDK5) is one of the cyclin-dependent kinases, and is expressed in mature neurons. CDK5 has been postulated to be a neurofilament or tau protein kinase, because it phosphorylates neurofilaments and tau protein (microtubule-associated protein tau) in vitro. It has been reported that CDK5 was immunohistochemically detected only in axons of neurons. We here report the immunohistochemical study of CDK5 using two distinct antibodies, one recognizing the N-terminal of CDK5 and the other the C-terminal. Immunoreactivity of CDK5 was found not only in axons, but also intensively in nuclei, though not in nucleoli, of neurons in the mouse central and peripheral nervous systems. The nuclear CDK5 possibly has a physiological function distinct from the neurofilament or tau protein kinase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891282     DOI: 10.1016/0006-8993(96)00523-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Nucleocytoplasmic transfer of cyclin dependent kinase 5 and its binding to puromycin-sensitive aminopeptidase in Dictyostelium discoideum.

Authors:  Robert J Huber; Danton H O'Day
Journal:  Histochem Cell Biol       Date:  2011-07-16       Impact factor: 4.304

2.  Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo.

Authors:  Steve D Haenchen; Jeff A Utter; Adam M Bayless; Rick T Dobrowsky; David J Davido
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

3.  Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo.

Authors:  H Ino; T Chiba
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 4.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

5.  Amino acid sequence conservation of the algesic fragment of myelin basic protein is required for its interaction with CDK5 and function in pain.

Authors:  Andrei V Chernov; Albert G Remacle; Swathi K Hullugundi; Piotr Cieplak; Mila Angert; Jennifer Dolkas; Veronica I Shubayev; Alex Y Strongin
Journal:  FEBS J       Date:  2018-08-27       Impact factor: 5.542

6.  Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo.

Authors:  Juliet Rashidian; Maxime W Rousseaux; Katerina Venderova; Dianbo Qu; Steve M Callaghan; Maryam Phillips; Ross J Bland; Matthew J During; Zixu Mao; Ruth S Slack; David S Park
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

7.  Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death.

Authors:  Kuei-Hua Chang; Parminder Singh Multani; Kai-Hui Sun; Fabien Vincent; Yolanda de Pablo; Soumitra Ghosh; Ritika Gupta; Hyun-Pil Lee; Hyoung-Gon Lee; Mark A Smith; Kavita Shah
Journal:  Mol Biol Cell       Date:  2011-03-09       Impact factor: 4.138

8.  Cdk5 Regulates Activity-Dependent Gene Expression and Dendrite Development.

Authors:  Zhuoyi Liang; Tao Ye; Xiaopu Zhou; Kwok-On Lai; Amy K Y Fu; Nancy Y Ip
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

9.  Regulation of Sox6 by cyclin dependent kinase 5 in brain.

Authors:  Parvathi Rudrabhatla; Elias Utreras; Howard Jaffe; Ashok B Kulkarni
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Stress-induced nuclear translocation of CDK5 suppresses neuronal death by downregulating ERK activation via VRK3 phosphorylation.

Authors:  Haengjin Song; Wanil Kim; Jung-Hyun Choi; Sung-Hoon Kim; Dohyun Lee; Choon-Ho Park; Sangjune Kim; Do-Yeon Kim; Kyong-Tai Kim
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.